Skip to main content
Top
Published in: Inflammation Research 7/2020

01-07-2020 | Short Communication

CHRFAM7A reduces monocyte/macrophage migration and colony formation in vitro

Authors: Theresa W. Chan, Simone Langness, Olga Cohen, Brian P. Eliceiri, Andrew Baird, Todd W. Costantini

Published in: Inflammation Research | Issue 7/2020

Login to get access

Abstract

Objective and design

CHRFAM7A is a unique human gene that encodes a dominant negative inhibitor of the α7 nicotinic acetylcholine receptor. We have recently shown that CHRFAM7A is expressed in human leukocytes, increases cel–cell adhesion, and regulates the expression of genes associated with leukocyte migration.

Material

Human THP-1, RAW264.7 and HEK293 cells.

Methods

Cell migration, cell proliferation and colony formation in soft agar to compare the biological activity of vector vs. CHRFAM7A-transduced cells.

Results

We show that gene delivery of CHRFAM7A into the THP-1 human monocytic cell line reduces cell migration, reduces chemotaxis to monocyte chemoattractant protein, and reduces colony formation in soft agar.

Conclusion

Taken together, the findings demonstrate that CHRFAM7A regulates the biological activity of monocytes/macrophages to migrate and undergo anchorage-independent growth in vitro.
Appendix
Available only for authorised users
Literature
2.
Metadata
Title
CHRFAM7A reduces monocyte/macrophage migration and colony formation in vitro
Authors
Theresa W. Chan
Simone Langness
Olga Cohen
Brian P. Eliceiri
Andrew Baird
Todd W. Costantini
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 7/2020
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-020-01349-7

Other articles of this Issue 7/2020

Inflammation Research 7/2020 Go to the issue